PENDARVIS DAVID
- SEC CIK
- 0001196723
在各公司的最新職務
- WDFC WD 40 CO董事2026/2/6 申報
- RMD RESMED INC行政長2023/6/30 申報
交易紀錄
所有把 PENDARVIS DAVID 列為申報人的 Form 4，包括與他人共同申報的。每一列是一份申報裡同一種交易的合計；預設只顯示公開市場買進（P）與賣出（S）。
| 公司 | 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|---|
| WDFCWD 40 CO | 2026/2/6 | 2026/2/5 | PENDARVIS DAVID董事 | P買進Common Stock | +424 | $247.15 | +$10.48 萬 | 6,898 | +6.5% | SEC |
| WDFCWD 40 CO | 2025/10/30 | 2025/10/30 | PENDARVIS DAVID董事 | P買進Common Stock | +523 | $196.37 | +$10.27 萬 | 5,862 | +9.8% | SEC |
| WDFCWD 40 CO | 2024/4/12 | 2024/4/12 | PENDARVIS DAVID董事 | P買進Common Stock | +328 | $234.75 | +$7.7 萬 | 4,934 | +7.1% | SEC |
| RMDRESMED INC | 2023/6/7 | 2023/6/5 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $219.79 | −$32.97 萬 | 8.97 萬 | −1.6% | SEC10b5-1 |
| RMDRESMED INC | 2023/5/4 | 2023/5/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $237.64 | −$35.65 萬 | 9.12 萬 | −1.6% | SEC10b5-1 |
| RMDRESMED INC | 2023/4/5 | 2023/4/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $218.23 | −$32.73 萬 | 9.27 萬 | −1.6% | SEC |
| RMDRESMED INC | 2023/3/7 | 2023/3/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $216.69 | −$32.5 萬 | 9.42 萬 | −1.6% | SEC |
| RMDRESMED INC | 2023/2/6 | 2023/2/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $224.50 | −$33.68 萬 | 9.57 萬 | −1.5% | SEC |
| RMDRESMED INC | 2023/1/5 | 2023/1/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $210.07 | −$31.51 萬 | 9.72 萬 | −1.5% | SEC |
| RMDRESMED INC | 2022/12/6 | 2022/12/5 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,500 | $229.81 | −$34.47 萬 | 9.87 萬 | −1.5% | SEC |
| RMDRESMED INC | 2022/11/4 | 2022/11/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $215.23 | −$33.25 萬 | 10.23 萬 | −1.5% | SEC |
| RMDRESMED INC | 2022/10/5 | 2022/10/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $220.19 | −$34.02 萬 | 10.39 萬 | −1.5% | SEC |
| RMDRESMED INC | 2022/9/7 | 2022/9/6 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $216.92 | −$33.51 萬 | 10.54 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/8/4 | 2022/8/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $240.72 | −$37.19 萬 | 10.53 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/7/6 | 2022/7/5 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $212.33 | −$32.8 萬 | 10.68 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/6/7 | 2022/6/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $209.44 | −$32.36 萬 | 10.84 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/5/4 | 2022/5/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,545 | $200.00 | −$30.9 萬 | 10.99 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/4/5 | 2022/4/4 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,544 | $246.60 | −$38.08 萬 | 11.14 萬 | −1.4% | SEC |
| RMDRESMED INC | 2022/3/4 | 2022/3/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,544 | $250.62 | −$38.7 萬 | 11.29 萬 | −1.3% | SEC |
| RMDRESMED INC | 2022/2/4 | 2022/2/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,544 | $232.87 | −$35.96 萬 | 11.45 萬 | −1.3% | SEC |
| RMDRESMED INC | 2022/1/4 | 2022/1/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,544 | $258.52 | −$39.92 萬 | 11.6 萬 | −1.3% | SEC |
| RMDRESMED INC | 2021/12/6 | 2021/12/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,544 | $257.93 | −$39.82 萬 | 11.76 萬 | −1.3% | SEC |
| RMDRESMED INC | 2021/11/5 | 2021/11/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,485 | $264.29 | −$39.25 萬 | 12.1 萬 | −1.2% | SEC |
| RMDRESMED INC | 2021/10/5 | 2021/10/4 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,487 | $260.79 | −$38.78 萬 | 12.25 萬 | −1.2% | SEC |
| RMDRESMED INC | 2021/9/7 | 2021/9/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,487 | $292.16 | −$43.44 萬 | 12.4 萬 | −1.2% | SEC |
| RMDRESMED INC | 2021/8/4 | 2021/8/3 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,487 | $269.38 | −$40.06 萬 | 12.34 萬 | −1.2% | SEC |
| RMDRESMED INC | 2021/7/7 | 2021/7/6 | PENDARVIS DAVID行政長 | S賣出ResMed Common Stock | −1,487 | $247.12 | −$36.75 萬 | 12.49 萬 | −1.2% | SEC |